Relapsed/Refractory AL Amyloidosis
1 clinical trials · Condition
◉ Watch Relapsed/Refractory AL Amyloidosis
| Record | Firm | Date |
|---|---|---|
| Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Amyloidosis (NCT07250269) | Gracell Biotechnologies (Shanghai) Co., Ltd. | 2025-10-29 |
Track Relapsed/Refractory AL Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.